Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBT (2016 - 2021)

Historic EBT for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$3.1 million.

  • ENDRA Life Sciences' EBT fell 3793.68% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year increase of 421.52%. This contributed to the annual value of -$11.5 million for FY2024, which is 1439.03% down from last year.
  • Latest data reveals that ENDRA Life Sciences reported EBT of -$3.1 million as of Q4 2021, which was down 3793.68% from -$2.7 million recorded in Q3 2021.
  • ENDRA Life Sciences' 5-year EBT high stood at -$741623.0 for Q1 2017, and its period low was -$4.8 million during Q4 2019.
  • For the 5-year period, ENDRA Life Sciences' EBT averaged around -$2.6 million, with its median value being -$2.7 million (2019).
  • As far as peak fluctuations go, ENDRA Life Sciences' EBT plummeted by 28096.22% in 2018, and later skyrocketed by 5319.98% in 2020.
  • Quarter analysis of 5 years shows ENDRA Life Sciences' EBT stood at -$2.3 million in 2017, then fell by 3.09% to -$2.4 million in 2018, then tumbled by 103.3% to -$4.8 million in 2019, then skyrocketed by 53.2% to -$2.3 million in 2020, then plummeted by 37.94% to -$3.1 million in 2021.
  • Its EBT was -$3.1 million in Q4 2021, compared to -$2.7 million in Q3 2021 and -$3.2 million in Q2 2021.